BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 24302621)

  • 1. p16 INK4a overexpression and p16/Ki-67 dual labeling versus conventional urinary cytology in the evaluation of urothelial carcinoma.
    Piaton E; Carré C; Advenier AS; Decaussin-Petrucci M; Mège-Lechevallier F; Lantier P; Granier G; Ruffion A
    Cancer Cytopathol; 2014 Mar; 122(3):211-20. PubMed ID: 24302621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p16(INK4a) /Ki-67 dual labelling as a marker for the presence of high-grade cancer cells or disease progression in urinary cytopathology.
    Piaton E; Advenier AS; Carré C; Decaussin-Petrucci M; Mege-Lechevallier F; Ruffion A
    Cytopathology; 2013 Oct; 24(5):327-34. PubMed ID: 23003335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16/Ki-67 dual labeling and urinary cytology results according to the New Paris System for Reporting Urinary Cytology: Impact of extended follow-up.
    Piaton E; Advenier AS; Carré C; Decaussin-Petrucci M; Mège-Lechevallier F; Hutin K; Nennig C; Colombel M; Ruffion A
    Cancer Cytopathol; 2017 Jul; 125(7):552-562. PubMed ID: 28371465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of p16(INK4a) in the diagnosis of low-grade urothelial carcinoma of the urinary bladder in urinary cytology.
    Alameda F; Juanpere N; Pijuan L; Lloveras B; Gimeno J; Baró T; Salido M; Serrano S; Lloreta J
    Cancer Cytopathol; 2012 Aug; 120(4):276-82. PubMed ID: 22419364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16(INK4a) overexpression is not linked to oncogenic human papillomaviruses in patients with high-grade urothelial cancer cells.
    Piaton E; Casalegno JS; Advenier AS; Decaussin-Petrucci M; Mege-Lechevallier F; Ruffion A; Mekki Y
    Cancer Cytopathol; 2014 Oct; 122(10):760-9. PubMed ID: 25069600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotyping of high-risk human papillomaviruses in p16/Ki-67-positive urothelial carcinoma cells: even a worm will turn.
    Advenier AS; Casalegno JS; Mekki Y; Decaussin-Petrucci M; Mège-Lechevallier F; Ruffion A; Piaton E
    Cytopathology; 2015 Apr; 26(2):106-13. PubMed ID: 24785530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combined application of urinary liquid-based cytology with fluorescence in situ hybridization and p16/Ki-67 dual immunostaining is valuable for improving the early diagnosis of upper tract urothelial carcinomas.
    Sun X; Liu X; Xia M; Yang S; Fei L; Zhang M; Ma H; Wang L; Chen S; Yu L
    Diagn Cytopathol; 2017 Oct; 45(10):895-902. PubMed ID: 28799728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16(INK4a) expression analysis as an ancillary tool for cytologic diagnosis of urothelial carcinoma.
    Nakazawa K; Murata S; Yuminamochi T; Ishii Y; Ohno S; Nakazawa T; Kondo T; Katoh R
    Am J Clin Pathol; 2009 Nov; 132(5):776-84. PubMed ID: 19846821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokeratin 20 immunocytochemistry on urine sediments: A potential low-cost adjunct to cytology in the diagnosis of low-grade urothelial carcinoma.
    Wadhwa N; Diwaker P; Lotha N; Arora VK; Singh N
    Cytopathology; 2017 Dec; 28(6):531-535. PubMed ID: 28940433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of pagetoid urothelial intraepithelial neoplasia extending to the vagina by cervical screening cytology: a case report with renewed immunochemical summary.
    Koyanagi Y; Kubo C; Nagata S; Ryu A; Hatano K; Kano R; Tanada S; Ashimura JI; Idota A; Kamiura S; Yamasaki T; Nakatsuka SI
    Diagn Pathol; 2019 Feb; 14(1):9. PubMed ID: 30711015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of urinary bladder urothelial carcinoma by immunocytology with p53, MCM5, MCM2 and Ki-67 antibodies using cell blocks derived from urine.
    Brisuda A; Háček J; Čechová M; Škapa P; Babjuk M
    Cytopathology; 2019 Sep; 30(5):510-518. PubMed ID: 30943322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cell-cycle regulatory proteins and their prognostic value in superficial low-grade urothelial cell carcinoma of the bladder.
    Santos LL; Amaro T; Pereira SA; Lameiras CR; Lopes P; Bento MJ; Oliveira J; Criado B; Lopes CS
    Eur J Surg Oncol; 2003 Feb; 29(1):74-80. PubMed ID: 12559081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ROS generation via NOX4 and its utility in the cytological diagnosis of urothelial carcinoma of the urinary bladder.
    Shimada K; Fujii T; Anai S; Fujimoto K; Konishi N
    BMC Urol; 2011 Oct; 11():22. PubMed ID: 22032647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpretation of p16(INK4a) /Ki-67 dual immunostaining for the triage of human papillomavirus-positive women by experts and nonexperts in cervical cytology.
    Allia E; Ronco G; Coccia A; Luparia P; Macrì L; Fiorito C; Maletta F; Deambrogio C; Tunesi S; De Marco L; Gillio-Tos A; Sapino A; Ghiringhello B
    Cancer Cytopathol; 2015 Apr; 123(4):212-8. PubMed ID: 25534957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inverse p16 and p63 expression in small cell carcinoma and high-grade urothelial cell carcinoma of the urinary bladder.
    Buza N; Cohen PJ; Pei Hui ; Parkash V
    Int J Surg Pathol; 2010 Apr; 18(2):94-102. PubMed ID: 20164052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of Ki-67 and p53 with the new World Health Organization/International Society of Urological Pathology Classification System for Urothelial Neoplasia.
    Cina SJ; Lancaster-Weiss KJ; Lecksell K; Epstein JI
    Arch Pathol Lab Med; 2001 May; 125(5):646-51. PubMed ID: 11300936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias.
    Nasser W; Flechtenmacher C; Holzinger D; Hofele C; Bosch FX
    J Oral Pathol Med; 2011 Sep; 40(8):629-35. PubMed ID: 21435003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative cytomorphological comparison of SurePath and ThinPrep liquid-based cytology using high-grade urothelial carcinoma cells.
    Okuda C; Kyotake A; Nakamura A; Itoh T; Kamoshida S; Ohsaki H
    Cytopathology; 2021 Sep; 32(5):654-659. PubMed ID: 34033150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocytochemical staining for p53 and Ki-67 helps to characterise urothelial cells in urine cytology.
    Courtade-Saïdi M; Aziza J; d'Aure D; Bérard E; Evrard S; Basset C; Lacoste-Collin L
    Cytopathology; 2016 Dec; 27(6):456-464. PubMed ID: 27873391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.